Silva Markovic-Plese
Affiliations: | Neurobiology | University of North Carolina, Chapel Hill, Chapel Hill, NC |
Area:
ImmunologyGoogle:
"Silva Markovic-Plese"Mean distance: 53433
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Seyedsadr M, Wang Y, Elzoheiry M, et al. (2023) IL-11 induces NLRP3 inflammasome activation in monocytes and inflammatory cell migration to the central nervous system. Proceedings of the National Academy of Sciences of the United States of America. 120: e2221007120 |
| Kiapour N, Wu B, Wang Y, et al. (2022) Therapeutic Effect of Anti-CD52 Monoclonal Antibody in Multiple Sclerosis and Its Animal Models Is Mediated via T Regulatory Cells. Journal of Immunology (Baltimore, Md. : 1950) |
| Montes M, Zhang X, Berthelot L, et al. (2022) Corrigendum to "Oligoclonal myelin-reactive T-cell infiltrates derived from neuromyelitis optica spectrum disorder (NMOSD) lesions are enriched in Th17 cells" [Clinical Immunology 130 (2009) 133-144]. Clinical Immunology (Orlando, Fla.). 108967 |
| Johnson BM, Uchimura T, Gallovic MD, et al. (2021) STING Agonist Mitigates Experimental Autoimmune Encephalomyelitis by Stimulating Type I IFN-Dependent and -Independent Immune-Regulatory Pathways. Journal of Immunology (Baltimore, Md. : 1950) |
| Zhang X, Kiapour N, Kapoor S, et al. (2019) IL-11 Induces Encephalitogenic Th17 Cells in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis. Journal of Immunology (Baltimore, Md. : 1950) |
| Zhang X, Kiapour N, Kapoor S, et al. (2018) IL-11 antagonist suppresses Th17 cell-mediated neuroinflammation and demyelination in a mouse model of relapsing-remitting multiple sclerosis. Clinical Immunology (Orlando, Fla.) |
| Sha Y, Markovic-Plese S. (2016) Activated IL-1RI Signaling Pathway Induces Th17 Cell Differentiation via Interferon Regulatory Factor 4 Signaling in Patients with Relapsing-Remitting Multiple Sclerosis. Frontiers in Immunology. 7: 543 |
| Tao Y, Zhang X, Markovic-Plese S. (2016) Toll-like receptor (TLR)7 and TLR9 agonists enhance interferon (IFN) beta-1a's immunoregulatory effects on B cells in patients with relapsing-remitting multiple sclerosis (RRMS). Journal of Neuroimmunology. 298: 181-8 |
| Tao Y, Zhang X, Zivadinov R, et al. (2015) Immunologic and MRI markers of the therapeutic effect of IFN-β-1a in relapsing-remitting MS. Neurology(R) Neuroimmunology & Neuroinflammation. 2: e176 |
| Dwyer MG, Zivadinov R, Tao Y, et al. (2015) Immunological and short-term brain volume changes in relapsing forms of multiple sclerosis treated with interferon beta-1a subcutaneously three times weekly: an open-label two-arm trial. Bmc Neurology. 15: 232 |